Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome
- 10 March 2011
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 164 (1), 100-107
- https://doi.org/10.1111/j.1365-2249.2011.04320.x
Abstract
Summary: Recurrent respiratory tract infections (RRTIs) are common clinical conditions in individuals with alterations of the immune function. A prospective open pilot study in a cohort of patients with RRTIs has been performed to assess whether sublingual immunization with a polyvalent bacterial vaccine could exert an immunomodulatory effect on the antigen-specific immunological responses and have an impact on the clinical outcome. Seventeen patients with RRTIs were recruited. An oral polyvalent bacterial preparation (Bactek®) was administered to all patients daily for 6 months. Immunological assessment was performed at baseline and at the end of immunization. Immunological measurements included: T cell-specific proliferations of CD3+CD4+ and CD3+CD8+ to Bactek® antigens, total immunoglobulin levels, antibodies to pneumococcal polysaccharide and tetanus toxoid and B, T and natural killer (NK) cell subsets. There was a significant increase in the proliferative capacity of CD3+CD4+ T cells specific to Bactek® antigens at month 6 in comparison to baseline (P < 0·0001). A significant increase in total CD3+ T cells was also observed (P < 0·05). No significant differences were observed between baseline and month 6 in levels of total immunoglobulins, specific antibodies and B, T or NK cell subsets. A significant reduction in the patient's rate of RRTIs was observed compared with 1 year prior to initiation of therapy (P < 0·0001). The results demonstrate that long-term administration of a sublingual polyvalent bacterial preparation in patients with RRTIs exerts an immune stimulating effect on CD4+ T helper cell responses to bacterial antigens which could be associated with clinical benefit.Keywords
This publication has 50 references indexed in Scilit:
- Patterns of Pathogenesis: Discrimination of Pathogenic and Nonpathogenic Microbes by the Innate Immune SystemCell Host & Microbe, 2009
- Sublingual vaccination with influenza virus protects mice against lethal viral infectionProceedings of the National Academy of Sciences of the United States of America, 2008
- Commentary on “Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic review”European Journal of Pediatrics, 2007
- Use of OM-85 BV for the Prevention of Acute Respiratory Tract Infections in Occupational MedicineJournal of International Medical Research, 2002
- Protection against influenza a virus infection in mice by oral immunization with a polyvalent bacterial lysateInternational Journal of Immunopharmacology, 1991
- Local Immunity in Patients with Chronic Bronchitis and the Effects of a Bacterial Extract, Broncho-Vaxom®, on T Lymphocytes, Macrophages, Gamma-Interferon and Secretory Immunoglobulin A in Bronchoalveolar Lavage Fluid and Other VariablesRespiration, 1990
- Stimulation by a bacterial extract (broncho-vaxom) of the metabolic and functional activities of murine macrophagesInternational Journal of Immunopharmacology, 1989
- Oral Immunotherapy of Chronic Bronchitis: a Double-Blind Placebo-Controlled Multicentre StudyRespiration, 1989
- Clinical and immunobiological effects of an orally administered bacterial extractInternational Journal of Immunopharmacology, 1984
- Immunoglobulin Production in Man Stimulated by an Orally Administered Bacterial LysateRespiration, 1980